The glucocorticoid hormones and their synthetic derivatives are potent supp
ressors of inflammatory and allergic pathologies. Their widespread efficacy
is the result of multiple modes of action occuring predominantly at the le
vel of the microcirculation. Indeed the glucocorticoids interfere with the
function of all of the cellular components of the microcirculation associat
ed with an inflammatory response. These agents inhibit vasodilatation of th
e arteriolar and capillary beds, therefore preventing the increase in blood
flow that characterizes the initial stages of the inflammatory response. T
hey also prevent increases in vascular permeability in the capillary and po
st-capillary venule, thereby reducing exudate formation. Finally, the gluco
corticoids potently suppress leukocyte emigration across post-capillary ven
ules. However, this promiscuity of the glucocorticods to act at multiple si
tes also endows this class of drugs with major side effects associated with
chronic treatment. We propose that one way to progress forward is to under
stand better the effects of glucocorticoids within the microcirculation. Th
is may aid identification of specific molecular sites of action and therefo
re the development of novel glucocorticoid molecules with fewer side effect
s.